Spike Protein Persistence and Long COVID Recovery: Evidence-Based Insights (2026)

By Editorial Team -

Abstract

Background: Persistent symptoms following SARS-CoV-2 infection, commonly referred to as Long COVID, affect a significant subset of patients. Spike protein persistence, immune dysfunction, and microvascular pathology have been proposed as contributing mechanisms.

Objective: To review current evidence regarding spike protein persistence, immune dysregulation, microclot formation, and systemic dysfunction in Long COVID, and to summarize evidence-informed recovery strategies.

Methods: A narrative review of peer-reviewed studies and public health guidance was conducted, focusing on immunology, vascular pathology, and persistent viral antigen detection in post-acute COVID-19 patients. Sources include Nature, Cell, Clinical Infectious Diseases, and The Lancet.

Results: Spike protein or viral RNA may persist in some individuals for months post-infection. Persistent immune activation, microclots, endothelial dysfunction, mitochondrial impairment, and dysautonomia are documented mechanisms contributing to fatigue, cognitive impairment, and exercise intolerance. No interventions have been demonstrated to directly remove spike protein; recovery strategies focus on multi-system support, including nutrition, gradual activity, and inflammation regulation.

Conclusions: Long COVID is a multi-systemic condition driven by persistent immune activation, endothelial injury, and metabolic dysfunction. Evidence-informed recovery focuses on systemic support rather than unproven “detox” interventions. Further research is required to define the prevalence and clinical significance of spike protein persistence.

1. Introduction

Long COVID is defined by the World Health Organization as symptoms persisting beyond 3 months of SARS-CoV-2 infection without alternative explanation (WHO, 2021). Symptoms frequently include fatigue, cognitive impairment, orthostatic intolerance, and dyspnea. Emerging hypotheses suggest that persistent viral antigens, immune dysregulation, and microvascular pathology contribute to these symptoms (Swank et al., 2023; Chertow et al., 2022).

The term “spike protein detox” has circulated in the public domain. However, no peer-reviewed evidence supports a direct method to remove spike protein. Instead, research highlights systemic mechanisms contributing to persistent symptoms.

2. Methods

A narrative literature review was performed, searching PubMed, Scopus, and high-impact journals for studies on Long COVID, spike protein persistence, immune dysfunction, and microclot formation.

Inclusion criteria:

  • Peer-reviewed articles published 2020–2023

  • Studies reporting viral antigen persistence, immune markers, vascular dysfunction, or clinical Long COVID outcomes

Exclusion criteria:

  • Preprints without peer review

  • Opinion pieces lacking data

3. Results

3.1 Spike Protein and Viral Persistence

Studies report detectable spike protein or viral RNA months post-infection:

  • Swank et al., 2023 observed circulating spike protein in a subset of Long COVID patients

  • Chertow et al., 2022 demonstrated viral RNA persistence in multiple organs, including the brain

  • Zollner et al., 2022 identified gut as a potential viral reservoir, implicating ongoing antigen exposure in systemic immune activation

3.2 Immune Dysregulation

Persistent immune activation is documented in several cohorts:

  • Su et al., 2022 identified autoantibodies and T-cell dysfunction predictive of post-acute sequelae

  • Phetsouphanh et al., 2022 demonstrated immune activation persisting up to 8 months post-infection

3.3 Vascular Dysfunction and Microclots

Microclots impair tissue oxygenation and contribute to fatigue and brain fog:

  • Pretorius et al., 2021 described amyloid fibrin microclots resistant to fibrinolysis

  • Kell et al., 2022 confirmed persistent microclots in Long COVID plasma

  • Endothelial injury is documented by Varga et al., 2020, indicating endotheliitis as a pathological contributor

3.4 Mitochondrial and Nervous System Dysfunction

  • Davis et al., 2021 reported chronic fatigue as a dominant symptom, correlating with mitochondrial dysfunction

  • Singh et al., 2020 identified impaired ATP production and oxidative stress

  • Dysautonomia, including POTS-like symptoms, is described in Blitshteyn & Whitelaw, 2021 and Raj et al., 2020

3.5 Recovery Strategies

Evidence-informed strategies focus on systemic support:

  • Immune regulation: sleep, stress management, nutrition (Su et al., 2022; Phetsouphanh et al., 2022)

  • Vascular health: gradual activity, hydration, omega-3 supplementation

  • Mitochondrial support: CoQ10, B vitamins, acetyl-L-carnitine

  • Gut health: fiber, fermented foods, microbiome diversity.

The many mechanisms of action involved in the ultimate removal of spike protein. Source: How to Get Rid of Spike Protein

4. Discussion

Long COVID represents a multi-systemic disorder driven by persistent immune activation, endothelial dysfunction, microclots, and mitochondrial impairment. The concept of “spike protein detox” is scientifically unsupported.

Recovery is optimized through multi-system support, emphasizing gradual rehabilitation, dietary strategies, and inflammation management. Further studies are needed to:

  1. Determine prevalence and functional significance of spike protein persistence

  2. Identify biomarkers predictive of recovery

  3. Evaluate interventions targeting vascular or mitochondrial dysfunction

5. Conclusion

Long COVID is a complex, multi-system condition. Current evidence emphasizes supporting physiological recovery rather than unproven detox strategies. Systemic interventions addressing immune function, vascular health, mitochondrial capacity, and gut integrity are consistent with current mechanistic understanding.

References

  1. Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881–895.e20. https://www.cell.com/cell/fulltext/S0092-8674(22)00072-1

  2. Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210–216. https://www.nature.com/articles/s41590-021-01113-x

  3. Swank Z, Senussi Y, Manickas-Hill Z, et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis. 2023;76(3):e487–e490. https://academic.oup.com/cid/article/76/3/e487/6649516

  4. Chertow DS, Stein S, Ramelli SC, et al. SARS-CoV-2 infection and persistence throughout the human body and brain. Nature. 2022;612:758–763. https://www.nature.com/articles/s41586-022-05542-y

  5. Zollner A, Koch R, Jukic A, et al. Post-acute COVID-19 is characterized by gut viral antigen persistence. Gastroenterology. 2022;163:2238–2250.e9. https://www.gastrojournal.org/article/S0016-5085(22)00450-4/fulltext

  6. Pretorius E, Venter C, Laubscher GJ, et al. Persistent clotting protein pathology in Long COVID. Cardiovasc Diabetol. 2021;20:172. https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01359-7

  7. Kell DB, Pretorius E. Fibrinaloid microclots in Long COVID. Front Cardiovasc Med. 2022;9:893613. https://www.frontiersin.org/articles/10.3389/fcvm.2022.893613/full

  8. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30937-5/fulltext

  9. Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an international cohort. EClinicalMedicine. 2021;38:101019. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00299-6/fulltext

  10. Singh KK, Chaubey G, Chen JY, et al. Mitochondrial dysfunction in COVID-19 pathogenesis. Front Physiol. 2020;11:611434. https://www.frontiersin.org/articles/10.3389/fphys.2020.611434/full

  11. Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome after COVID-19. Neurology. 2021;97:e1086–e1090. https://n.neurology.org/content/97/10/e1086

  12. Raj SR, Guzman JC, Harvey P, et al. Postural tachycardia syndrome (POTS): mechanisms and management. Circulation. 2020;141:139–150. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.040914

  13. World Health Organization. Post COVID-19 condition (Long COVID) clinical case definition. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1

Comments

Post a Comment

Popular posts from this blog

Dr Peter McCullough: How to Detox Spike Protein from Body

By Editorial Team -
Image
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body.  I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day Bromelain 500 mg once a day Nano/Liposomal Curcumin 500 mg twice a day Related: Nattokinase, Bromelain and Curcumin from The Wellness Company Additional products can be added, including NAC, IVM (Ivermectin), HCQ (Hydroxychloroquine), fluvoxamine, low-dose naltrexone, and blood thinners, depending on the clinical evaluation and the syndrome. The therapeut...
Read more

Dr Peter McCullough: Spike protein detox protocol explained (2026)

By Editorial Team -
Image
Dr. McCullough explained that the spike protein is an engineered, synthetic molecule roughly 1,200 amino acids long and resistant to degradation by the body’s normal proteases. He described how the protein was modified in laboratory settings (notably at the Wuhan Institute of Virology) to tightly bind to the ACE2 receptor, which is found throughout the body—in the lungs, heart, endothelium, kidneys, and brain. Because this receptor regulates angiotensin metabolism, older individuals with fewer ACE2 sites catabolize the spike less efficiently, leading to worse outcomes. Whether introduced by infection or by genetic‑code‑based vaccines, McCullough asserted, the persistent spike damages tissues directly and through chronic inflammation, micro‑clotting, and autoimmune cross‑reactivity. He cited more than 300 papers documenting spike deposits in the heart, brain, and vascular tissue, relating these findings to post‑vaccine myocarditis, strokes, and clotting disorders. A chief diagnostic ste...
Read more

Dr Peter McCullough: Povidone Iodine, Oral and Nasal Hygiene (2025)

By Editorial Team -
Image
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Updates:  Double blind randomized controlled trial of saline solution gargling and nasal rinsing in COVID infection (Nov 2023) What really killed COVID-19 patients: It wasn't a cytokine storm, suggests study  (2023) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the pr...
Read more

FLCCC I-CARE Treatment Protocol for Flu and RSV (2025)

By Editorial Team -
Image
A Guide to Diagnosing and Managing Influenza and Respiratory Syncytial Virus (RSV) Infections in Adults In adult patients, COVID-19 (Omicron variant), influenza, and RSV present with similar symptoms and can, therefore, be difficult to distinguish. This guide aims to help diagnose and treat Influenza and Respiratory Syncytial Virus (RSV). Update: Oseltamivir Treatment vs Supportive Care for Seasonal Influenza Requiring Hospitalization (JAMA 2025) For advice on how to protect yourself against infection, see  I-PREVENT: COVID, Flu and RSV Protection Protocol . For treatment of COVID-19, see  I-CARE: Early COVID Treatment Protocol . For treatment of Post Vaccine Complications, see I-RECOVER: Post Vaccine Treatment . Update: Added Minocycline (Jan 2023 update) Note that there are two I-Care Protocols; the I-Care Covid protocol to treat Covid and this protocol, I-Care Flu protocol.  About this Protocol The information in this document is our recommended approach to COVID-19 ...
Read more

How to Remove Spike Protein from Body: FLCCC I-Recover Protocol

By Editorial Team -
Image
Can you remove spike proteins from your body? Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC*, which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a private tele-health practice specializing in the treatment of COVID-19, so-called "long-COVID" and post-vaccine syndrome. *The FLCCC Alliance is now the  Independent Medical Alliance Note that there are significant overlaps between the symptoms and features of long COVID/long-hauler syndrome and post-vaccine syndrome. However, a number of clinical features appear to be characteristic of post-vaccine syndrome; most notably, severe neurological symptoms appear to be more common following vaccination. To c...
Read more

FLCCC I-Recover Protocol: Post Vaccine Treatment Protocol (2025)

By Editorial Team -
Image
Over the last three years, the COVID-19 pandemic has transformed almost every aspect of our lives before we've had time to stop and question it. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC ( The FLCCC Alliance is now the Independent Medical Alliance ), which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a priva...
Read more

Find a Doctor to prescribe Hydroxychloroquine, Ivermectin and Early Outpatient Treatments (2025)

By Editorial Team -
Image
Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. 'Early' treatment will make significant difference in outcome as opposed to late treatment.  Related: How can I get Ivermectin? See the directory of professionals in US below. Directory of Doctors (by State) Prescribing Effective Outpatient COVID-19 Therapy USA ​ MULTIPLE STATES (Telemedicine or online consultation) The Wellness Company ( twc.health ) Medical Specialty: Family Medicine, Functional Medicine Supported Protocols: I-PREVENT (COVID Protection), I-CARE (Early at-home treatment), I-RECOVER (Long COVID and Post-Vaccine treatment) Dr. Miguel Antonatos (IVM) (855) 767-8559  https://text2md.com (States: AL, AZ, CO, FL, GA, IA, ID, IL, KS, KY, MD, ME, MI, MN, MS, ND, NE, NJ, NV, OK, SC, SD, TN, UT, VT, WA, WI, WV) ...
Read more

Dr Peter McCullough: How to Measure Your Spike Protein Antibody (2025)

By Editorial Team -
Image
In clinic today I want to address the most common question I get from patients, “have I been exposed to the SARS-CoV-2 Spike protein through infection, shedding, or vaccination, and what should I do about it?” This video will explain that you can now take matters into your own hands and order a Spike protein antibody test from Labcorp Labs On Demand and get the results within a few days. Here is a quick guide of interpretation of your results: <1000 U/ml very low level past exposure, negligible risks 1000-5000 U/ml symptoms or problem could be related to Spike protein >5000 U/ml Spike protein likely circulating in your bloodstream 10,000-25,000 U/ml very high risk for cardiac damage, blood clots, neurologic problems, autoimmunity, and potentially cancer Remember the antibodies are an indirect reflection of Spike protein and do not change quickly. My advice is not to check the test again for a year. Above is one of my patients who has resolved his Spike syndrome with detoxificat...
Read more

Are ‘Turbo Cancers’ Real? Inside the Rise of Early-Onset Cancer (2026)

By Editorial Team -
Image
For years, clinicians and patients have described a disturbing pattern — cancers appearing suddenly, growing at unexpected speed, or diseases thought stable returning aggressively within weeks or months. A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way. Some called them “turbo cancers”. In oncology, the phenomenon is known as hyper-progression: cancers that accelerate far more rapidly than expected. Early on, these reports were ignored. They surfaced as scattered cases — isolated anecdotes that were easy to dismiss. One of the first to speak publicly was Belgian immunologist Michel Goldman, whose story was published in The Atlantic in 2022. He believed the Covid-19 vaccine may have accelerated his lymphoma. Shortly after vaccination and boosting, he developed swollen lymph nodes, fatigue and night sweats. Imaging revealed ...
Read more

Front Line Doctors Ivermectin Protocol for Prevention and Treatment of COVID-19 (2025)

By Editorial Team -
Image
The Front Line COVID-19 Critical Care (FLCCC*) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate.  *The FLCCC Alliance is now the  Independent Medical Alliance Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the   I-MASK+ protocol   ( is now divided into I-Prevent and I-Care protocols ) for prophylaxis and at home treatment of early stage COVID-19. Quercetin, zinc and a number of nutrients and drugs are part of this protocol, not only for critical care but also for prophylaxis and mild disease being treated at home. This article, we will dive deeper to provide the scientific background, related references and rationale of the FLCCC protocols. December 2025 Update: The Stratus Variant (XFG): Symptoms, Global Spread, and Impact in Late 2025 FLCCC ( ...
Read more

Labels

Show more